Narottam Acharya

Employment

• Institute of Life Sciences Scientist -F
  2011 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (27)

• PCNA-Polκ-Polδ/USP18 axes stabilize replication fork and restart to reduce cisplatin cytotoxicity
  2026 DOI: 10.7554/eLife.112155.1
  +Save
• PCNA-Polκ-Polδ/USP18 axes stabilize replication fork and restart to reduce cisplatin cytotoxicity
  2026 DOI: 10.64898/2026.06.08.730955
  +Save
• Differential functions of human DNA polymerase delta with p12 variants during DNA replication and DNA damage response
  Molecular Biology of the Cell 2026 DOI: 10.1091/mbc.E25-12-0580
  +Save
• PCNA-Polκ-Polδ/USP18 axes stabilize replication fork and restart to reduce cisplatin cytotoxicity
  2026 DOI: 10.7554/eLife.112155
  +Save
• Author Correction: Immunogenicity and efficacy of CNA25 as a potential whole-cell vaccine against systemic candidiasis
  EMBO Molecular Medicine 2025 DOI: 10.1038/s44321-025-00263-x
  +Save
• Enzymatic and Structural Roles of Candida albicans Rev1 in DNA Damage Response and Disseminated Candidiasis
  Molecular Microbiology 2025 DOI: 10.1111/mmi.70013
  +Save
• A chemically-induced attenuated strain of Candida albicans generates robust protective immune response and prevents systemic candidiasis development
  2024 DOI: 10.7554/eLife.93760.1
  +Save
• Hsp90-Mediated Multi-Drug Resistance in DNA Polymerase-Defective Strains of Candida albicans
  Journal of Fungi 2024 DOI: 10.3390/jof10030222
  +Save
• A chemically-induced attenuated strain of Candida albicans generates robust protective immune responses and prevents systemic candidiasis development
  2024 DOI: 10.7554/eLife.93760.2
  +Save
• Immunogenicity and efficacy of CNA25 as a potential whole-cell vaccine against systemic candidiasis
  EMBO Molecular Medicine 2024 DOI: 10.1038/s44321-024-00080-8
  +Save